Stockreport

Capricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular Dystrophy

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF -- Conference Call Today at 1 PM ET/10 AM PT --                                                   LOS ANGELES, July 17, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics [Read more]